FATE
Ticker
Fate Therapeutics, Inc.
FATE · Healthcare · Fate Therapeutics, Inc., a clinical-stage biopharmaceutical company, develops programmed cellular immunotherapies for cancer and immune dis…Fate Therapeutics, Inc. (FATE), in the Healthcare sector, has 1 disclosed filing on Paydirt over the trailing twelve months from 1 corporate insider: 0 purchases and 1 sale. Filers took a median of 1 day from execution to disclosure, and the most recent trade was executed Aug 4 and filed Aug 5. The most active filer was Jeremy Green with 1 filing.
Add to watchlistFilings, ttm
1
0 buys · 1 sell
Traders, ttm
1
1 insider
Volume, ttmiDollar value disclosed in the window
$108K
estimated for Congress, as filed for insiders
Median delay
1d
execution to disclosure
Last traded
Aug 4
Filed Aug 5
ADViAverage daily dollar volume
$9.7M
market data
Share price · 12M
$2.62 (+159.4%)
Adjusted for splits and dividends.
Volume by month
Buys $669K
Sells $682K
Estimated for Congress, as filed for insiders · by filing month · past 24 months
Who filed
JG
Jeremy Green
Director
1 filing
BVRecent filings
Bahram ValamehrSALE
President and CEO
$108K43,947 sh × $2.46
Exec Aug 4
Filed Aug 5 · 4:01 PM ET Jeremy GreenSALE Director $574K
341,633 sh × $1.68
Exec Dec 20 2024
Filed Dec 26 2024 · 5:30 PM ET † Jeremy GreenPURCHASE Director $669K
397,964 sh × $1.68
Exec Dec 20 2024
Filed Dec 26 2024 · 5:30 PM ET †